GSK Chief Acknowledges Chinese Bribery Allegations Probably True – ValueWalk Premium
GlaxoSmithKline

GSK Chief Acknowledges Chinese Bribery Allegations Probably True

GlaxoSmithKline plc (ADR) (NYSE:GSK) Andrew Witty said that it appeared the allegations of corruption by four GSK executives in China were probably true, calling the situation “personally deeply disappointing,” reports Denise Roland with The Telegraph.

GlaxoSmithKline (GSK) is being investigated

GlaxoSmithKline plc . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk
0